Page last updated: 2024-09-02

tanshinone and plerixafor

tanshinone has been researched along with plerixafor in 1 studies

Compound Research Comparison

Studies
(tanshinone)
Trials
(tanshinone)
Recent Studies (post-2010)
(tanshinone)
Studies
(plerixafor)
Trials
(plerixafor)
Recent Studies (post-2010) (plerixafor)
1,445101,0331,312113930

Protein Interaction Comparison

ProteinTaxonomytanshinone (IC50)plerixafor (IC50)
C-X-C chemokine receptor type 4Rattus norvegicus (Norway rat)0.108
C-C chemokine receptor type 2Homo sapiens (human)0.0001
C-X-C chemokine receptor type 4Homo sapiens (human)0.3717

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Han, H; Hong, D; Qiao, H; Tong, Y; Wu, Y; Xu, W; Yang, J; Zhou, C1

Other Studies

1 other study(ies) available for tanshinone and plerixafor

ArticleYear
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Apr-15, Volume: 18, Issue:6

    Topics: Abietanes; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds; Male; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Salvia miltiorrhiza; Stem Cell Transplantation; Up-Regulation

2011